We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
BYOT's consumer sales to 'rest of the world', excluding US & UK is 0 (ZERO).
From Annual Report:
REVENUE Professional Consumer Pet Total
United Kingdom 2,254 164 283 2,701
North America 5 2,020 - 2,025
Rest of World 451 - 483 934
https://byotrolplc.com/wp-content/uploads/2019/10/Byotrol-Annual-Report-FY-2018-19.pdf
Further they lost the contract with a leading European Supplier, Robert McBride plc.
Loss of potential consumer sales during the outbreak, especially in Europe...
Major European supplier, Robert McBride - Tesco - "Excellent arrangement .. for many years:
"Post year end we came to the end of our licence relationship with Robert McBride plc and therefore to supplying surface sprays to Tesco. This was an excellent arrangement for us for many years, but it has now run its course and we expect to generate higher margin opportunities with better brand equity from other consumer initiatives. "
https://byotrolplc.com/wp-content/uploads/2019/10/Byotrol-Annual-Report-FY-2018-19.pdf
I see STD is still posting zzzz, why are you still coming here deramping?
The company have already stated their financial position.
read the highlighted bits from the company annual report.
"which is sufficient to finance our ONGOING operations .....but NOT to fund ADDITIONAL resources, CAPABILITIES and nationwide marketing expenditure in the US."
"Financial Resources
At the year-end we had cash resources of £2.8m (2018: £3.85m) which is sufficient to finance our ongoing operations and the remaining earnout payments to Medimark’s vendors but not to fund additional resources, capabilities and nationwide marketing expenditure in the US."
https://byotrolplc.com/wp-content/uploads/2019/10/Byotrol-Annual-Report-FY-2018-19.pdf
Broomfield
Yes opportunities and hope..
Their 1st patent was around 25yrs ago.
They IPO around 15yrs.
Yet their sales and sp spiked during previous outbreaks but despite that they supply to only 20+ hospitals.
They lost the Tesco contract recently.
Their 18 month trial at Target stores ends next month.
They didn't seize opportunities after previous outbreaks.
Is it any different this time?
"Invirtu alcohol-free hand sanitiser increased across all Professional customers. At year end our products were in over 20 UK NHS hospitals, including 2 total conversions from suppliers of alcohol-based products."
https://byotrolplc.com/wp-content/uploads/2019/10/Byotrol-Annual-Report-FY-2018-19.pdf
Hi Trek - just for clarity, I'm in agreement with your stance on this one.
The only caveat I have, is the Co really have to galvanise themselves and really optimise the opportunity market conditions present. Time will tell if they can truly achieve this. Clearly, I think they sill.
All the best.
B
Absolutely Broomfielder, you’ve done a better job of assessing the potential risk against the Sp than stt who keeps looking back. The crux is can the BoD capitalise on the cv news. As simple as that. I am biased with a substantial holding now in the yes camp, you are by the sounds of it hedging a little in just in case, fine, and stt still can’t quite get his head around it. But then he’s obviously, imo, being paid. The volume here and the sp rise, (just look at the charts of byot and ncyt, very similar) says it all really.
Now what will happen if we get an RNS linking our products with cv? It’ll come.
Trek
I'm new to Byotrol and while IMO it may be no firework stock, it really should be building into the increasing global healthcare awareness brought into sharp focus by the coronovirus crisis and the potential for superbugs generally to wreak havoc with our world today.
We all know there are no guarantees in life and, certainly not in AIM, but today's marketplace for the Company's products provides management with a huge opportunity.
They just have to take it!
B
INVIRTU is now sold out for all new customers lucky for their distributors.
stt1 is still hiding under his duvet this morning.
The more STD posts the more it goes up, has to be the worst deramper I have EVER seen, if you was a horse you would have been put down now buddy. Its inhuman watching your pathetic attempts at deramping
Very risky buying into a company with accounting irregularities, don't you think 1gw???
"The Directors have made every effort to resolve this matter to our auditor’s satisfaction, without success. Whilst it may have been possible eventually to obtain a suitable response, the length of time this may have required was indeterminate, and the Board took the decision that the interests of shareholders were best served by publishing the accounts with the consequential qualified audit opinion but resulting in the lifting in the suspension from trading on AIM. Since the year end we have transferred over £86,000 of the aggregate amount from the bank concerned to another commercial bank and intend to transfer the balance shortly"
https://byotrolplc.com/wp-content/uploads/2019/10/2019-10-11-Posting-of-accounts-and-restoration-B-3.6.pdf
One of the selling points of this company as an investment, in my opinion, is the skin in the game that both the CEO and the Chairman have. Click on the "BYOT Directors Deals" tab on this site and note the "holding" and the prices they have been buying at.
OldTown
"As I pointed out last week the CEO only earns £120k a year" "he can’t afford £50k"
Didn't you read the director dealing rns of 30th January then??
The rns clearly shows the non-Exec CHAIRMAN and CFO bought 1m and 500k, respectively...
Which equates to about £16k and £8k.
Not only did you post the wrong person but massively overstated the value of the director buys.
Emailed the company today and they replied two hours later I was more than impressed with their four paragraphs.
Trek. I love your persistence with the resident idiot. As I pointed out last week the CEO only earns £120k a year. Hardly a fat cat. He can’t afford £50k to buy shares on his salary. Leave the troll to fester in his own dribble and underpants
Not all directors are multi-millionaires and the rules only prevent buying on a close period. Doing or not doing deals on aim is not always an exception, it can be bau. The directors obviously just felt they could throw some money away!
Trek
They supply Invirtu hand sanitiser in 'over 20' hospitals...so probably not many over '20'...
That's not many, given they have been listed for 15yrs...and also given other outbreaks since they listed.
The 'hope' is that they might gain more contracts...
"Invirtu alcohol-free hand sanitiser increased across all Professional customers. At year end our products were in over 20 UK NHS hospitals, including 2 total conversions from suppliers of alcohol-based products."
https://byotrolplc.com/wp-content/uploads/2019/10/Byotrol-Annual-Report-FY-2018-19.pdf
STD seriously change your tune, youre still barking on about 1 product, 1 product seriously get a new job buddy
Trek
"what a joke a 13m MCAP is "
£13m mcap for a company 'hoping' to gain contracts.
The trial at Target ends at the end of next month, any news of it rolling out at all Target stores or of partnerships. It's already around 6 weeks since Covid-19 outbreak was announced.
They lost the Tesco contract in UK. Any news on another retailer to take their place.
"Post year end we came to the end of our licence relationship with Robert McBride plc and therefore to supplying surface sprays to Tesco. This was an excellent arrangement for us for many years, but it has now run its course and we expect to generate higher margin opportunities with better brand equity from other consumer initiatives. "
Boots have been out of stock of 200ml bottles for 10 days now. Loss of 'potential' customers.
Trek
"purchased 1,000,000 and 500,000 ordinary shares"
The recent rise is based on 'hope' that the company signs new partnerships.
The director purchases from only 2 weeks ago show that they were NOT about to sign any partnership deals...
Plus 1m & 500k shares cost around £18k and £9k respectively.... Not really much for Company Officers.
“on 30 January 2020, John Langlands, Non-Executive Chairman of the Company, and Nic Hellyer, Chief Financial Officer of the Company, purchased 1,000,000 and 500,000 ordinary shares of 0.25p each”....because the accounts are bent! Nah! Read through RNS and understand aim rules, this isn’t same as main market regs and directors buy out of close periods when the FUTURE looks bright....
Trek
5 months now since they mentioned irregularities on their accounts for fy2019.. Has anyone seen any news on whether their fy accounts have been qualified?
"The Directors have made every effort to resolve this matter to our auditor’s satisfaction, without success. Whilst it may have been possible eventually to obtain a suitable response, the length of time this may have required was indeterminate, and the Board took the decision that the interests of shareholders were best served by publishing the accounts with the consequential qualified audit opinion but resulting in the lifting in the suspension from trading on AIM. Since the year end we have transferred over £86,000 of the aggregate amount from the bank concerned to another commercial bank and intend to transfer the balance shortly"
https://byotrolplc.com/wp-content/uploads/2019/10/2019-10-11-Posting-of-accounts-and-restoration-B-3.6.pdf
STD you arent doing a very good job deramping this fella, it keeps going up
"no PR needed .. til we break 2.4p"
Of course the company should be Marketing their products during this unexpected outbreak.. Currently, there's just hope that they will gain partners, which they need...
What will happen when the outbreak becomes old news and they haven't gained any partnerships??? - £10m mcap built on 'hope'!!
no PR needed IMO till we break 2.4p